SAB: First MERS treatment appears safe in clinical trial
The anti-MERS immunotherapy developed by Sioux Falls biotech company SAB Biotherapeutics Inc. appears safe in phase 1 clinical trials, the company announced.
The anti-MERS immunotherapy developed by Sioux Falls biotech company SAB Biotherapeutics Inc. appears safe in phase 1 clinical trials, the company announced.
Connecting to a therapist who can listen and provide support is now as easy as chatting on your smartphone.
Avera McKennan’s new CEO lives by the motto: “Let’s do the right thing for the right reasons at the right time.” Get to know David Flicek, who has gone from being born in the hospital to leading it.
Virtual Incision, a company significantly funded by Sioux Falls private equity, could change the way surgery is performed with this incredible robot.
There’s a big development to announce for SAB Biotherapeutics, which has spent the past year testing its technology in a patient.
Just in time for those new year’s resolutions, Sanford Health has revamped its wellness experience to include upgrades and access to multiple facilities.
A mission known as Friends for Health in Haiti has a friend in Avera.
Profile by Sanford has developed a new test designed to tell how people are genetically wired to metabolize carbohydrates.
A Sioux Falls company has received approval from the FDA to market its signature Omega-3 Index test as an over-the-counter, general health and wellness product.
Longtime Avera Health president and CEO John Porter is retiring.